To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC79272 | N-Demethylonalespib |
N-Demethylonalespib is a ligand for E3 ligase. N-Demethylonalespib can be used for synthesis of DDO3602.
More description
|
|
| DC79254 | Dihydrouracil-Ph-2-Me-piperidine |
Dihydrouracil-Ph-2-Me-piperidine is an E3 ligase ligand. Dihydrouracil-Ph-2-Me-piperidine can be used to synthesize PROTAC HPK1 Degrader-6.
More description
|
|
| DC79195 | Nef ligand-2 |
Nef ligand-2 is a binder of Nef. Nef ligand-2 is Ligands for E3 Ligase. Nef ligand-2 is the Nef Binder portion of FC-14369.
More description
|
|
| DC79044 | Thalidomide-C4-N2-C2-N3 |
Thalidomide-C4-N2-C2-N3 is an E3 ligase ligand. Thalidomide-C4-N2-C2-N3 can bind to a target protein ligand with a linker to form a PROTAC molecule, PROTAC sEH-degrader-4.
More description
|
|
| DC78933 | E3 ligase Ligand 58 |
E3 ligase Ligand 58 is an E3 ligase ligand. E3 ligase Ligand 58 can be used for synthesis of PROTAC AH078.
More description
|
|
| DC78911 | E3 ligase Ligand 76 |
E3 ligase Ligand 76 is a E3 ligase ligand that can be used in the recruitment of VHL protein. E3 ligase Ligand 76 can be connected to the KRAS ligand by a linker to synthesis of PROTAC KRAS(on) degrader ACBI-4.
More description
|
|
| DC78828 | Thalidomide-C-amide-C5-amine |
Thalidomide-C-amide-C5-amine is an E3 ligase ligand. Thalidomide-C-amide-C5-amine can be used for synthesis of PROTAC BET Degrader-10.
More description
|
|
| DC78750 | OICR-41103N |
OICR-41103N is the negative control form of OICR-41103. OICR-41103 is an effective, selective, cell-active DCAF1 small molecule chemical probe (Ki<2 nM) that targets the DCAF1 WDR domain and replaces the viral Vpr protein.
More description
|
|
| DC78749 | OICR-41103 |
OICR-41103 is an effective, selective, cell-active DCAF1 small molecule chemical probe that targets the DCAF1 WDR domain and replaces the viral Vpr protein. The binding Ki value of OICR-41103 and DCAF1 is less than 2 nM.
More description
|
|
| DC78748 | (S,S,S)-AHPC-Me |
(S,S,S)-AHPC-Me is an E3 ligase ligand. (S,S,S)-AHPC-Me can be used for synthesis of PROTAC (4S)-PROTAC SOS1 degrader-1 diTFA.
More description
|
|
| DC78731 | E3 ligase Ligand 60 |
E3 ligase Ligand 60 is a ligand for E3 ligase, used for the synthesis of JV8.
More description
|
|
| DC78727 | (R,S,S)-VH032-Me TFA |
(R,S,S)-VH032-Me TFA is an E3 ligase Ligand and can be used for synthesis of dTAGV-1 hydrochloride.
More description
|
|
| DC78692 | CRBN ligand-186 |
CRBN ligand-186 is a CRBN-type E3 ubiquitin ligase ligand that can be used to prepare PROTAC.
More description
|
|
| DC78682 | E3 ligase Ligand 77 |
E3 ligase Ligand 77 is a CRBN type E3 ubiquitin ligase ligand. E3 ligase Ligand 77 can be used for synthesizing PROTAC, such as PROTAC RET Degrader 1.
More description
|
|
| DC78659 | E3 ligase Ligand 75 |
E3 ligase Ligand 75 is an E3 ligase ligand. E3 ligase Ligand 75 can be used for synthesis PROTAC K-Ras Degrader-7.
More description
|
|
| DC78597 | Deoxy-thalidomide-OMe |
Deoxy-thalidomide-OMe is an E3 ligase ligand. Deoxy-thalidomide-OMe can be used for synthesis of PROTAC LRRK2 Degrader-4.
More description
|
|
| DC78572 | Brigatinib A |
Brigatinib A is an GID4 ligand. Brigatinib A can be used for synthesizing PROTAC BCR-ABL Degrader-2.
More description
|
|
| DC78498 | 6-(2,4-Dioxopyrimidin-1-yl)-1-methylindole |
6-(2,4-Dioxopyrimidin-1-yl)-1-methylindole is an E3 ligase ligand used in the synthesis of the PROTAC Androgen receptor degrader-1.
More description
|
|
| DC78487 | XB2M54 |
XB2M54 is a selective XIAP antagonist. XB2M54 inhibits NOD2-mediated inflammatory signaling. XB2M54 is an E3 ligase ligand. XB2M54 can be used for synthesis of PROTAC ERα Degrader-1.
More description
|
|
| DC78218 | XIAP ligand 5 |
XIAP ligand 5 is a XIAP antagonist. XIAP ligand 5 is an E3 ligase ligand. XIAP ligand 5 can be used for synthesis of PROTAC GNE-1567.
More description
|
|
| DC78217 | CDK12-Cyclin K ligand-1 |
CDK12-Cyclin K ligand-1 is a ligand of PROTAC degrader that binds to the E3 ligase. CDK12-Cyclin K ligand-1 can be used in the synthesis of PROTAC degrader such as PP-C8.
More description
|
|
| DC78213 | (S,S,S)-VH032 |
(S,S,S)-VH032 is the ligand for E3 Ligase (VHL) that can be used for synthesis of PROTAC SGK3 degrader-2.
More description
|
|
| DC78212 | (R,S,R)-AHPC-Me-Ac |
(R,S,R)-AHPC-Me-Ac is an E3 ligase ligand used in the synthesis of the PROTAC SHP2 Protein degrader-2.
More description
|
|
| DC78208 | E3 ligase Ligand 68 |
E3 ligase Ligand 68 is an E3 ligase ligand that can be used in the synthesis of PROTACs, such as PROTAC ER Degrader-3.
More description
|
|
| DC78174 | JY-5 |
JY-5 is an E3 ligase ligand. JY-5 can be used for synthesis of PROTAC JY-21.
More description
|
|
| DC78067 | E3 ligase Ligand 66 |
E3 ligase Ligand 66 is an E3 ligase ligand that can be used to recruit IAP proteins. E3 ligase Ligand 66 can be linked to SARS-CoV-2 Mpro ligand 1 through a linker to form PROTAC BP-198.
More description
|
|
| DC47206 | Thalidomide-5-CH2-NH2 hydrochloride Featured |
Thalidomide-5-CH2-NH2 (hydrochloride) is the Thalidomide-based cereblon ligand used in the recruitment of CRBN protein. Thalidomide-5-CH2-NH2 (hydrochloride) can be connected to the ligand for protein by a linker to form PROTACs.
More description
|
|
| DC72888 | Z0933M Featured |
Z0933M is a potent S phase kinase-associated protein 1 (Skp1) inhibitor with Kd of 54 nM, potently inhibits Skp1-F-box protein-protein interactions with Ki value of 231 nM in FP-based in vitro competition assays.
More description
|
|
| DC12249 | E3 ligase Ligand 1 dihydrochloride |
E3 ligase Ligand 1 dihydrochloride is a Hippel-Landau (VHL) E3 ligase-binding moiety based on PROTAC technology.
More description
|
|
| DC47216 | Thalidomide-5,6-F Featured |
Thalidomide-5,6-F is the Thalidomide-based cereblon ligand used in the recruitment of CRBN protein. Thalidomide-5,6-F can be connected to the ligand for protein by a linker to form PROTACs.
More description
|
|